| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000015655 |
| Receipt No. | R000018199 |
| Official scientific title of the study | Reserch of liver failure biomaker after a hepatectomy |
| Date of disclosure of the study information | 2014/11/11 |
| Last modified on | 2016/05/11 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Reserch of liver failure biomaker after a hepatectomy | |
| Title of the study (Brief title) | Reserch of liver failure biomaker after a hepatectomy | |
| Region |
|
|
| Condition | ||
| Condition | the patient accepting a major hepatectomy | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Serch for liver failure biomaeker after mojor hepatectomy. |
| Basic objectives2 | Others |
| Basic objectives -Others | Reserch of the relations between some cytokine, vWF, and ADAMTS13 and liver failure after major hepatectomy. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase I,II |
| Assessment | |
| Primary outcomes | The rate of liver failure after a mojor hepatectomy. |
| Key secondary outcomes | mortality rate, complication rate, hospitalization days |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | von Willebrand factor
ADAMTS13 MCP-1 Procalcitonin Endotoxin Activity Assay HMGB-1 Interleukin-1beta,4,6,10 |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | a patient accepting major hepatectomy | |||
| Key exclusion criteria | patient of disagreement | |||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Ryusei Matsuyama |
| Organization | Yokohama city university |
| Division name | Depertment of gastroenterologicl surgery |
| Address | 3-13, Fukuura, Kanazawa-ku, Yokohama |
| TEL | 045-787-2650 |
| ryusei@terra.dti.ne.jp | |
| Public contact | |
| Name of contact person | Yusuke Suwa |
| Organization | Yokohama city university |
| Division name | Depertment of gastroenterologicl surgery |
| Address | 3-13, Fukuura, Kanazawa-ku, Yokohama |
| TEL | 045-787-2650 |
| Homepage URL | |
| yusuke_232002@yahoo.co.jp | |
| Sponsor | |
| Institute | Yokohama city university
Depertment of gastroenterologicl surgery |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Yokohama city university
Depertment of gastroenterologicl surgery |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 横浜市立大学附属病院(神奈川県)、 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018199 |